3,938
Views
4
CrossRef citations to date
0
Altmetric
Cornea and Conjunctiva

Different Approach to Manage Demodex Blepharitis – Initial and Maintenance Treatment

, , ORCID Icon, &
Pages 352-360 | Received 29 Mar 2021, Accepted 30 Aug 2021, Published online: 26 Sep 2021

References

  • Lee SH, Chun YS, Kim ES, Kim JC. The relationship between Demodex and ocular discomfort. Invest Ophtalmol Vis Sci. 2010;51:2906–11. doi:10.1167/iovs.09-4850.
  • Koo H, Kim TH, Kim KW, Wee SW, Chun YS, Kim JC. Ocular surface discomfort and Demodex: effectof tea tree oil eyelid scrub in Demodex blepharitis. J Korean Med Sci. 2012;27(12):1574–79. doi:10.3346/jkms.2012.27.12.1574.
  • Gao -Y-Y, Di Pascuale MA, Li W, Liu DT-S, Baradaran-Rafii A, Elizondo AUA. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005 September;46(9):3089–94. doi:10.1167/iovs.05-0275.
  • Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom. 2018;10:57–63. doi:10.2147/OPTO.S142708.
  • Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006 January;19(1):50–62. doi:10.1128/CMR.19.1.50-62.2006.
  • Navel V, Mulliez A, Benoist d’Azy C, Baker JS, Malecaze J, Chiambaretta F, Dutheil F. Efficacy of treatments for Demodex blepharitis: a systematic review and meta-analysis. Ocul Surf. 2019 Oct;17(4):655–69. doi:10.1016/j.jtos.2019.06.004.
  • Tighe S, Gao -Y-Y, Tseng SCG. Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites. Transl Vis Sci Technol. 2013 November;2(7):2. doi:10.1167/tvst.2.7.2.
  • Rah MJ. A review of hyaluronan and its ophthalmic applications. Optometry. 2011;82(1):38–43. doi:10.1016/j.optm.2010.08.003.
  • Chen LH, Xue JF, Zheng ZY, Shuhaidi M, Thu HE, Hussain Z. Hyaluronic acid, an efficient biomacromolecule for treatment of inflammatory skin and joint diseases: a review of recent developments and critical appraisal of preclinical and clinical investigations. Int J Biol Macromol. 2018;116:572–84. doi:10.1016/j.ijbiomac.2018.05.068.
  • Bukhari SNA, Roswandi NL, Waqas M, Habib H, Hussain F, Khan S, Sohail M, Ramli NA, Thu HE, Hussain Z, et al. Hyaluronic acid, a promising skin rejuvenating biomedicine: a review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects. Int J Biol Macromol. 2018;120(Pt B):1682–95. doi:10.1016/j.ijbiomac.2018.09.188.
  • Messaoud R, El Fekih L, Mahmoud A, Amor HB, Bannour R, Doan S, Khairallah M. Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe. Clinl Ophthalmol. 2019;13:1043–54. doi:10.2147/OPTH.S198585.
  • Ngo W, Jones L, Bitton E. Short-term comfort responses associated with the use of eyelid cleasning products to manage Demodex folliculorum. Eye Contact Lens. 2018;44(6):87–92. doi:10.1097/ICL.0000000000000415.
  • Muntz A, Purslow C, Wolffsohn JS, Craig JP. Improved Demodex diagnosis in the clinical setting using a novel in situ technique. Cont Lens Anterior Eye. 2020 Aug;43(4):345–49. doi:10.1016/j.clae.2019.11.009.
  • Lacey N, Kavanagh K, Tseng SC. Under the lash: Demodex mites in human diseases. Biochem (Lond). 2009 Aug 1;31(4):2–6.
  • Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Indian J Dermatol. 2014 Jan;59(1):60–66. doi:10.4103/0019-5154.123498.
  • Bitton E, Ngo W, Dupont P. Eyelid hygiene products: a scoping review. Contact Lens Anterior Eye. 2019;42:591–97. doi:10.1016/j.clae.2019.09.008.
  • Nicholls SG, Oakley CL, Tan A, Vote BJ. Demodex treatment in external ocular disease: the outcomes of a tasmanian case series. Int Ophtalmol. 2016;36(5):691–96. doi:10.1007/s10792-016-0188-5.
  • Gao YX, Xu DL, Huang LJ, Wang R, Tseng SC. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment. Cornea. 2012;13(1):14–17. doi:10.1097/ICO.0b013e31820ce56c.